Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens.

Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens. Abstract Text:

Walter R Weiss,Anita Kumar,George Jiang,Jackie Williams,Anthony Bostick,Solomon Conteh,David Fryauff,Joao Aguiar,Manmohan Singh,Derek T O'Hagan,Jeffery B Ulmer,Thomas L Richie,

BACKGROUND: We have previously described a four antigen malaria vaccine consisting of DNA plasmids boosted by recombinant poxviruses which protects a high percentage of rhesus monkeys against Plasmodium knowlesi (Pk) malaria. This is a multi-stage vaccine that includes two pre-erythrocytic antigens, PkCSP and PkSSP2(TRAP), and two erythrocytic antigens, PkAMA-1 and PkMSP-1(42kD). The present study reports three further experiments where we investigate the effects of DNA dose, timing, and formulation. We also compare vaccines utilizing only the pre-erythrocytic antigens with the four antigen vaccine. METHODOLOGY: In three experiments, rhesus monkeys were immunized with malaria vaccines using DNA plasmid injections followed by boosting with poxvirus vaccine. A variety of parameters were tested, including formulation of DNA on poly-lactic co-glycolide (PLG) particles, varying the number of DNA injections and the amount of DNA, varying the interval between the last DNA injection to the poxvirus boost from 7 to 21 weeks, and using vaccines with from one to four malaria antigens. Monkeys were challenged with Pk sporozoites given iv 2 to 4 weeks after the poxvirus injection, and parasitemia was measured by daily Giemsa stained blood films. Immune responses in venous blood samples taken after each vaccine injection were measured by ELIspot production of interferon-gamma, and by ELISA. CONCLUSIONS: 1) the number of DNA injections, the formulation of the DNA plasmids, and the interval between the last DNA injection and the poxvirus injection are critical to vaccine efficacy. However, the total dose used for DNA priming is not as important; 2) the blood stage antigens PkAMA-1 and PkMSP-1 were able to protect against high parasitemias as part of a genetic vaccine where antigen folding is not well defined; 3) immunization with PkSSP2 DNA inhibited immune responses to PkCSP DNA even when vaccinations were given into separate legs; and 4) in a counter-intuitive result, higher interferon-gamma ELIspot responses to the PkCSP antigen correlated with earlier appearance of parasites in the blood, despite the fact that PkCSP vaccines had a protective effect.

Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens. Publishing Authors By Initials

WR Weiss,A Kumar,G Jiang,J Williams,A Bostick,S Conteh,D Fryauff,J Aguiar,M Singh,DT O'Hagan,JB Ulmer,TL Richie,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: PLoS ONE

VOLUME: 2

Page Numbers: e1063

Journal Abbreviation: PLoS ONE

ISSN: 1932-6203

DAY: 24

MONTH: 10

YEAR: 2007

Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101285081

Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens.

AFFILIATION: Naval Medical Research Center, Silver Spring, Maryland, United States of America.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: PLoS ONE

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens Related Publications

• Assessing mortality risk in COPD.
• Biomechanics and clinical analysis of the adult acquired flatfoot.
• CT evaluation of advanced seminoma treated with chemotherapy.
• Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers.
• Detection of retroperitoneal metastases in early-stage nonseminomatous testicular cancer: analysis of different CT criteria.
• Domestic violence: emerging issues.
• Functional significance of the GAG trinucleotide-repeat polymorphism in the gene for the catalytic subunit of gamma-glutamylcysteine ligase.
• Glutathione depletion and recovery after acute ethanol administration in the aging mouse.
• High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R, Division of Hematology-Oncology, Indiana University School of Medicine, Indianapolis, IN.
• Impact of diagnostic delay in testis cancer: Results of a large population-based study Huyghe E, Muller A, Mieusset R, Bujan L, Bachaud JM, Chevreau C, Plante P, Thonneau P, Human Fertility Research Group, Paule de Viguier Hospital, Toulouse University II
• Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors Carver BS, Serio AM, Bajorin D, Motzer RJ, Stasi J, Bosl GJ, Vickers AJ, Sheinfeld J. Department of Urology, Sidney Kimmel Center for Prostate and Urologic
• Inhibition of caspase-3 activity and activation by protein glutathionylation.
• Is full bilateral retroperitoneal lymph node dissection always necessary for post-chemotherapy residual tumor? Beck SD, Foster RS, Bihrle R, Donohue JP, Einhorn LH, Department of Urology and Oncology, Indiana University Medical Center, Indianapolis, IN.
• Malaria vaccines for travelers.
• Management of the incidental renal mass.
• Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer Walsh TJ, Dall'Era MA, Croughan MS, Carroll PR, Turek PJ, Department of Urology, University of California San Francisco, San Francisco, CA.
• Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens.
• Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology.
• Simulation of elevated T-waves of an ECG inside a static magnetic field (MRI).
• Sonography of the male genital tract.
• The effects of vowel identification training on sentence-level speech recognition.
• Thymus medulla formation and central tolerance are restored in IKKalpha-/- mice that express an IKKalpha transgene in keratin 5+ thymic epithelial cells.
• Underwriting idiopathic interstitial lung diseases.